Wells Fargo & Company Global X Fds Genomics & Biotec Transaction History
Wells Fargo & Company
- $407 Billion
- Q2 2024
A detailed history of Wells Fargo & Company transactions in Global X Fds Genomics & Biotec stock. As of the latest transaction made, Wells Fargo & Company holds 1 shares of GNOM stock, worth $10. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1
Previous 0
Infinity%
Holding current value
$10
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding GNOM
# of Institutions
66Shares Held
2.92MCall Options Held
0Put Options Held
200-
One Capital Management, LLC Westlake Village, CA680KShares$7.06 Million0.26% of portfolio
-
Raymond James Financial Services Advisors, Inc. St. Petersburg, FL337KShares$3.5 Million0.01% of portfolio
-
Portland Global Advisors LLC253KShares$2.63 Million0.36% of portfolio
-
Mirae Asset Global Etfs Holdings Ltd. Central, K3200KShares$2.07 Million0.01% of portfolio
-
Lido Advisors, LLC Los Angeles, CA150KShares$1.56 Million0.01% of portfolio